Patent · US Active

Bispecific HER2 antibodies and methods of use

US11787873B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Rebecca CROASDALE-WOOD · Penzberg, DE
Lydia Jasmin Hanisch · Schlieren, CH
Guy Georges · Habach, DE
Thomas Hofer · Zürich, CH
Ralf Hosse · Baar, CH
Christian Klein · Iffeldorf, DE
Ekkehard Moessner · Kreuzlingen, CH
Samuel Moser · Rotkreuz, CH
Wolfgang Schaefer · Sankt Augustin, DE
Juergen Michael Schanzer · Traunstein, DE
Werner Scheuer · Penzberg, DE
Claudio Sustmann · Munich, DE
Pablo Umana · Wollerau, CH

Key dates

Filing date	Jan 16, 2020
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Apr 3, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to bispecific HER2 antibodies, novel HER2 antibody variants, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.